Reducing ribavirin and adding EPO are both good anaemia management strategies for people taking boceprevir
Abbott interferon-free combination 'promising' in harder-to-treat patients with hepatitis C
High rate of response to BMS HCV drugs in harder-to-treat patients – but interferon-free prospects differ by sub-genotype
Final study results show telaprevir is safe and effective for HIV/HCV co-infected people
New hepatitis C drugs danoprevir and mericitabine are safe and effective for prior non-responders and people with cirrhosis
Sofosbuvir appears safe and effective for HIV/HCV co-infected people
